Gene: AVIL
Official Full Name: advillinprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the gelsolin/villin family of actin regulatory proteins. This protein has structural similarity to villin. It binds actin and may play a role in the development of neuronal cells that form ganglia. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31618 | AVIL Knockout cell line (HeLa) | Human | AVIL | 1:3~1:6 | Negative | Online Inquiry |
KO31619 | AVIL Knockout cell line (HCT 116) | Human | AVIL | 1:2~1:4 | Negative | Online Inquiry |
KO31620 | AVIL Knockout cell line (HEK293) | Human | AVIL | 1:3~1:6 | Negative | Online Inquiry |
AVIL Gene Knockout Cell Lines are specialized cellular models engineered to lack the AVIL gene, a critical component involved in various biological processes such as cellular adhesion, migration, and signal transduction. These cell lines provide researchers with a powerful tool to investigate the role of AVIL in physiological and pathological contexts, facilitating studies into disorders such as cancer, cardiovascular diseases, and neurological conditions.
The key function of AVIL Gene Knockout Cell Lines lies in their ability to simulate the absence of the AVIL protein, thereby enabling the study of downstream effects and compensatory mechanisms that occur in gene loss scenarios. By leveraging techniques such as CRISPR-Cas9 gene editing, these cell lines allow for precise manipulation of genetic conditions, offering insights into gene function and intercellular interactions. Researchers can observe differences in cellular behaviors, gene expression profiles, and metabolic pathways, providing invaluable data to elucidate the contribution of AVIL to various biological processes.
The scientific significance of AVIL Gene Knockout Cell Lines extends to both research and clinical settings. In preclinical studies, these models aid in drug development by providing more accurate representations of disease states devoid of the AVIL protein, thus helping to identify novel therapeutic targets. Furthermore, their unique properties make them ideal candidates for the study of gene therapy approaches and the development of personalized medicine strategies.
Compared to alternative gene knockout models, AVIL Gene Knockout Cell Lines boast several advantages, including high specificity, reproducibility, and a user-friendly application process. These advantages allow for time-efficient experimentation and reliable results, which are crucial for a fast-paced research environment.
The value of AVIL Gene Knockout Cell Lines to researchers and clinicians lies in their potential to unlock new avenues for understanding gene function and mechanisms of disease. With these cell lines, users can drive forward innovative research that may ultimately lead to breakthroughs in treatment methodologies and improve patient outcomes.
Our company specializes in the development and provision of high-quality biological products tailored for cutting-edge scientific research. With a commitment to excellence and innovation, we strive to empower researchers with the tools they need to make significant advancements in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.